The presence of a non-silent somatic mutation in TP53 was associated with modestly poorer CRC survival in all cases combined (HR = 1.27, 95% CI: 1.01–1.59, Supplementary Data 2). The gene discussed is TP53; the disease is colorectal carcinoma.